The Need of Personalized Medicine in Coping with Stress during Infertility Treatment
Abstract
:1. Introduction
2. Results
2.1. Characteristics of the Study Group (n = 456)
2.2. Characteristics/Reproductive History of the Study Participants
3. Discussion
4. Materials and Methods
4.1. Ethical Consideration
4.2. The Course of the Study
4.3. 10-Item Perceived Stress Scale (PSS-10)
4.4. Mini-COPE Inventory
5. Conclusions and Clinical Implications
Limitations
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Bragazzi, N.L. From P0 to P6 medicine, a model of highly participatory, narrative, interactive, and “augmented” medicine: Some considerations on Salvatore Iaconesi’s clinical story. Patient Prefer Adherence 2013, 7, 353–359. [Google Scholar] [CrossRef] [PubMed]
- Agharezaee, N.; Hashemi, M.; Shahani, M.; Gilany, K. Male Infertility, Precision Medicine and Systems Proteomics. J. Reprod. Infertil. 2018, 19, 185–192. [Google Scholar] [PubMed]
- Ziegelstein, R.C. Personomics: The missing link in the evolution from precision medicine to personalized medicine. J. Pers. Med. 2017, 7, 11. [Google Scholar] [CrossRef]
- Beim, P.Y.; Elashoff, M.; Hu-Seliger, T.T. Personalized reproductive medicine on the brink: Progress, opportunities and challenges ahead. Reprod. BioMed. Online 2013, 27, 611–623. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hood, L.; Balling, R.; Auffray, C. Revolutionizing medicine in the 21st century through systems approaches. Biotechnol. J. 2012, 7, 992–1001. [Google Scholar] [CrossRef] [Green Version]
- Donzelli, G.; McGreevy, K.S. Perinatal care at the confluence of narrative medicine and personalized medicine: What lies downstream? J. Matern. Fetal Neonatal Med. 2016, 29, 2807–2809. [Google Scholar] [CrossRef] [Green Version]
- Pravettoni, G.; Gorini, A. A P5 cancer medicine approach: Why personalized medicine cannot ignore psychology. J. Eval. Clin. Pract. 2011, 17, 594–596. [Google Scholar] [CrossRef]
- Sadeghi, M.R. How Can Personalized Medicine Improve Assisted Reproduction Technology Outcomes? J. Reprod. Infertil. 2017, 18, 265. [Google Scholar]
- Twilt, M. Precision medicine: The new era in medicine. EbioMedicine 2016, 4, 24–25. [Google Scholar] [CrossRef] [Green Version]
- Capobianco, E. Systems and precision medicine approaches to diabetes heterogeneity: A Big Data perspective. Clin. Transl. Med. 2017, 6, 23. [Google Scholar] [CrossRef]
- Leopold, J.A.; Loscalzo, J.M. Emerging role of precision medicine in cardiovascular disease. Circ. Res. 2018, 122, 1302–1315. [Google Scholar] [CrossRef] [PubMed]
- Pearson, M.J.; Grover, L.M.; Lord, J.M.; Jones, S.W.; Davis, E.T. Bearings in hip arthroplasty: Joint registries vs precision medicine: Review article. HSS J. 2017, 13, 20–27. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Schumann, G.; Binder, E.B.; Holte, A.; de Kloet, E.R.; Oedegaard, K.J.; Robbins, T.W.; Ciccocioppo, R. Stratified medicine for mental disorders. Eur. Neuropsychopharmacol. 2014, 24, 5–50. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Collins, S.C. Precision reproductive medicine: Multigene panel testing for infertility risk assessment. J. Assist. Reprod. Gene. 2017, 34, 967–973. [Google Scholar] [CrossRef]
- Zhang, P.Y.; Yu, Y. Precise Personalized Medicine in Gynecology Cancer and Infertility. Front. Cell Dev. Biol. 2020, 7, 382. [Google Scholar] [CrossRef]
- Wass, J.A.; Stewart, P.M. (Eds.) Oxford Textbook of Endocrinology and Diabetes; Oxford University Press: Oxford, UK, 2011; Available online: https://oxfordmedicine.com/view/10.1093/med/9780199235292.001.1/med-9780199235292-chapter-9412 (accessed on 30 September 2020).
- Greil, A.L.; Slauson-Blevins, K.; McQuillan, J. The experience of infertility: A review of recent literature. Sociol. Health Illn. 2010, 32, 140–162. [Google Scholar] [CrossRef] [Green Version]
- Rooney, K.L.; Domar, A.D. The relationship between stress and infertility. Dialogues Clin. Neurosci. 2018, 20, 41. [Google Scholar]
- Huppelschoten, A.; Van-Dongen, A.; Verhaak, C.; Smeenk, J.; Kremer, J.; Nelen, W. Differences in quality of life and emotional status between infertile women and their partners. Hum. Reprod. 2013, 28, 2168–2176. [Google Scholar] [CrossRef] [Green Version]
- Nagórska, M.; Bartosiewicz, A.; Obrzut, B.; Darmochwał-Kolarz, D. Gender Differences in the Experience of Infertility Concerning Polish Couples: Preliminary Research. Int. J. Environ. Res. Public Health 2019, 16, 2337. [Google Scholar] [CrossRef] [Green Version]
- Dana, S.; Narimani, M.; Mikaeili, N. Comparison of emotion regulation and emotion control in fertile and infertile women. Intl. J. Phys. Beh. Res. 2013, 2, 250–254. [Google Scholar]
- Peterson, B.D.; Newton, C.R.; Rosen, K.H.; Skaggs, G.E. Gender differences in how men and women who are referred for IVF cope with infertility stress. Hum. Reprod. 2006, 21, 2443–2449. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wu, G.; Yin, T.; Yang, J.; Xu, W.; Zou, Y.; Wang, Y.; Wen, J. Depression and coping strategies of Chinese women undergoing in-vitro fertilization. Eur. J. Obstet. Gynecol. Reprod. Biol. 2014, 183, 155–158. [Google Scholar] [CrossRef] [PubMed]
- Mohammadi, M.; Samani, R.O.; Navid, B.; Maroufizadeh, S.; Sabeti, S. Coping strategy in infertile couples undergoing assisted reproduction treatment. Middle East Fertil. Soc. J. 2018, 23, 482–485. [Google Scholar] [CrossRef]
- Karaca, A.; Unsal, G. Psychosocial problems and coping strategies among Turkish women with infertility. Asian Nurs. Res. 2015, 9, 243–250. [Google Scholar] [CrossRef] [Green Version]
- Alosaimi, F.D.; Bukhari, M.; Altuwirqi, M.; Habous, M.; Madbouly, K.; Abotalib, Z.; Binsaleh, S. Gender differences in perception of psychosocial distress and coping mechanisms among infertile men and women in Saudi Arabia. Hum. Fertil. 2017, 20, 55–63. [Google Scholar] [CrossRef]
- Pottinger, A.M.; McKenzie, C.; Fredericks, J.; DaCosta, V.; Wynter, S.; Everett, D.; Walters, Y. Gender differences in coping with infertility among couples undergoing counselling for In Vitro Fertilization treatment. West Indian Med. J. 2006, 55, 237–242. [Google Scholar] [CrossRef]
- Babore, A.; Stuppia, L.; Trumello, C.; Candelori, C.; Antonucci, I. Male factor infertility and lack of openness about infertility as risk factors for depressive symptoms in males undergoing assisted reproductive technology treatment in Italy. Fertil. Steril. 2017, 107, 1041–1047. [Google Scholar] [CrossRef] [Green Version]
- Pasch, L.A.; Holley, S.R.; Bleil, M.E.; Shehab, D.; Katz, P.P.; Adler, N.E. Addressing the needs of fertility treatment patients and their partners: Are they informed of and do they receive mental health services? Fertil. Steril. 2016, 106, 209–215. [Google Scholar] [CrossRef] [Green Version]
- Holley, S.R.; Pasch, L.A.; Bleil, M.E.; Gregorich, S.; Katz, P.K.; Adler, N.E. Prevalence and predictors of major depressive disorder for fertility treatment patients and their partners. Fertil. Steril. 2015, 103, 1332–1339. [Google Scholar] [CrossRef] [Green Version]
- Patel, A.; Sharma, P.S.V.N.; Kumar, P. Role of Mental Health Practitioner in Infertility Clinics: A Review on Past, Present and Future Directions. J. Hum. Reprod. Sci. 2018, 11, 219–228. [Google Scholar] [CrossRef]
- Masoumi, S.Z.; Garousian, M.; Khani, S.; Oliaei, S.R.; Shayan, A. Comparison of quality of life, sexual satisfaction and marital satisfaction between fertile and infertile couples. Int. J. Fertil. Steril. 2016, 10, 290–296. [Google Scholar] [PubMed]
- Caruso, S.; Iraci, M.; Cianci, S.; Vitale, S.G.; Fava, V.; Cianci, A. Effects of long-term treatment with Dienogest on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain. J. Pain Res. 2019, 12, 2371–2378. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zarbo, C.; Brugnera, A.; Frigerio, L.; Malandrino, C.; Rabboni, M.; Bondi, E.; Compare, A. Behavioral, cognitive, and emotional coping strategies of women with endometriosis: A critical narrative review. Arch. Womens Ment. Health 2018, 21, 1–13. [Google Scholar] [CrossRef] [PubMed]
- Manne, S.L.; Kashy, D.A.; Virtue, S.; Criswell, K.R.; Kissane, D.W.; Ozga, M.; Heckman, C.J.; Stapleton, J.; Rodriguez, L. Acceptance, social support, benefit-finding, and depression in women with gynecological cancer. Qual. Life Res. 2018, 27, 2991–3002. [Google Scholar] [CrossRef] [PubMed]
- Zegers-Hochschild, F.; Adamson, G.D.; De Mouzon, J.; Ishihara, O.; Mansour, R.; Nygren, K.; Sullivan Evan der Poel, S. The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009. Hum. Reprod. 2009, 24, 2683–2687. [Google Scholar] [CrossRef] [Green Version]
- Kuczyński, W.; Kurzawa, R.; Oszukowski, P.; Pawelczyk, L.; Poręba, R.; Radowicki, S.; Szamatowicz, M.; Wołczyński, S. Rekomendacje dotyczące diagnostyki i leczenia niepłodności–skrót. Ginekol. Pol. 2012, 83, 149–154. [Google Scholar]
- Juczyński, Z.; Ogińska-Bulik, N. Narzędzia Pomiaru Stresu i Radzenia Sobie ze Stresem; Pracownia Testów Psychologicznych PTP: Warszawa, Poland, 2012. [Google Scholar]
- Cohen, S.; Kamarck, T.; Mermelstein, R. A global measure of perceived stress. J. Health Soc. Behav. 1983, 385–396. [Google Scholar] [CrossRef]
- Carver, C.S.; Scheier, M.F.; Weintraub, J.K. Assessing coping strategies: A theoretically based approach. J. Pers. Soc. Psychol. 1989, 56, 267–283. [Google Scholar] [CrossRef]
Items | M | Me | SD | Min. | Max. |
---|---|---|---|---|---|
1. In the last month, how often have you been upset because of something that happened unexpectedly? | 2.50 | 2 | 0.94 | 0 | 4 |
2. In the last month, how often have you felt that you were unable to control the important things in your life? | 1.86 | 2 | 1.07 | 0 | 4 |
3. In the last month, how often have you felt nervous and “stressed”? | 2.70 | 3 | 0.97 | 0 | 4 |
4. In the last month, how often have you felt confident about your ability to handle your personal problems? | 2.20 | 2 | 1.39 | 1 | 7 |
5. In the last month, how often have you felt that things were going your way? | 1.97 | 2 | 1.20 | 1 | 7 |
6. In the last month, how often have you found that you could not cope with all the things that you had to do? | 1.77 | 2 | 1.03 | 0 | 4 |
7. In the last month, how often have you been able to control irritations in your life? | 1.93 | 2 | 1.05 | 1 | 4 |
8. In the last month, how often have you felt that you were on top of things? | 1.90 | 2 | 0.92 | 1 | 4 |
9. In the last month, how often have you been angered because of things that were outside of your control? | 2.14 | 2 | 0.99 | 0 | 4 |
10. In the last month, how often have you felt difficulties were piling up so high that you could not overcome them? | 1.89 | 2 | 1.09 | 0 | 4 |
PSS-10 (0–40 points scale) | 20.87 | 20 | 5.30 | 7 | 38 |
Scale 0–3 Points | M | Me | SD | Min. | Max. |
---|---|---|---|---|---|
1. I’ve been turning to work or other activities to take my mind off things. | 1.98 | 2 | 0.84 | 0 | 3 |
2. I’ve been concentrating my efforts on doing something about the situation I’m in. | 2.21 | 2 | 0.65 | 0 | 3 |
3. I’ve been saying to myself "this isn’t real". | 0.86 | 1 | 0.83 | 0 | 3 |
4. I’ve been using alcohol or other drugs to make myself feel better | 0.46 | 0 | 0.69 | 0 | 3 |
5. I’ve been getting emotional support from others. | 1.70 | 2 | 0.86 | 0 | 3 |
6. I’ve been giving up trying to deal with it. | 0.80 | 1 | 0.73 | 0 | 3 |
7. I’ve been taking action to try to make the situation better. | 2.31 | 2 | 0.66 | 0 | 3 |
8. I’ve been refusing to believe that it has happened. | 1.09 | 1 | 0.88 | 0 | 3 |
9. I’ve been saying things to let my unpleasant feelings escape. | 1.45 | 1.5 | 0.86 | 0 | 3 |
10. I’ve been getting help and advice from other people. | 1.64 | 2 | 0.87 | 0 | 3 |
11. I’ve been using alcohol or other drugs to help me get through it. | 0.42 | 0 | 0.68 | 0 | 3 |
12. I’ve been trying to see it in a different light, to make it seem more positive. | 1.76 | 2 | 0.79 | 0 | 3 |
13. I’ve been criticizing myself. | 1.30 | 1 | 0.88 | 0 | 3 |
14. I’ve been trying to come up with a strategy about what to do. | 2.10 | 2 | 0.70 | 0 | 3 |
15. I’ve been getting comfort and understanding from someone. | 1.78 | 2 | 0.81 | 0 | 3 |
16. I’ve been giving up the attempt to cope. | 0.74 | 1 | 0.75 | 0 | 3 |
17. I’ve been looking for something good in what is happening. | 1.83 | 2 | 0.72 | 0 | 3 |
18. I’ve been making jokes about it. | 1.40 | 1 | 0.90 | 0 | 3 |
19. I’ve been doing something to think about it less, such as going to movies, watching TV, reading, daydreaming, sleeping, or shopping. | 1.67 | 2 | 0.86 | 0 | 3 |
20. I’ve been accepting the reality of the fact that it has happened. | 1.86 | 2 | 0.74 | 0 | 3 |
21. I’ve been expressing my negative feelings. | 1.41 | 1 | 0.81 | 0 | 3 |
22. I’ve been trying to find comfort in my religion or spiritual beliefs. | 1.33 | 1 | 0.96 | 0 | 3 |
23. I’ve been trying to get advice or help from other people about what. | 1.56 | 2 | 0.87 | 0 | 3 |
24. I’ve been learning to live with it. | 1.87 | 2 | 0.74 | 0 | 3 |
25. I’ve been thinking hard about what steps to take. | 2.16 | 2 | 0.69 | 0 | 3 |
26. I’ve been blaming myself for things that happened | 1.19 | 1 | 0.86 | 0 | 3 |
27. I’ve been praying or meditating. | 1.38 | 1 | 1.00 | 0 | 3 |
28. I’ve been making fun of the situation. | 0.41 | 0 | 0.62 | 0 | 3 |
Scale 0–3 pts. | Mean | Me | SD | Min. | Max. |
---|---|---|---|---|---|
AC | 2.26 | 2 | 0.56 | 0 | 3 |
P | 2.13 | 2 | 0.59 | 0 | 3 |
PR | 1.80 | 2 | 0.65 | 0 | 3 |
A | 1.86 | 2 | 0.63 | 0 | 3 |
SH | 0.91 | 1 | 0.61 | 0 | 2.5 |
R | 1.36 | 1.5 | 0.92 | 0 | 3 |
UES | 1.74 | 2 | 0.76 | 0 | 3 |
UIS | 1.60 | 1.5 | 0.77 | 0 | 3 |
SD | 1.82 | 2 | 0.69 | 0 | 3 |
D | 0.97 | 1 | 0.73 | 0 | 3 |
V | 1.43 | 1.5 | 0.62 | 0 | 3 |
SU | 0.44 | 0 | 0.65 | 0 | 3 |
BD | 0.77 | 1 | 0.61 | 0 | 3 |
SB | 1.24 | 1 | 0.76 | 0 | 3 |
Mini-COPE | General (n = 456) | Women (n = 235) | Men (n = 221) | |||
---|---|---|---|---|---|---|
rho | p | rho | p | rho | p | |
AC | 0.001 | 0.9895 | −0.012 | 0.8505 | −0.001 | 0.9854 |
P | −0.004 | 0.9297 | −0.001 | 0.9906 | −0.031 | 0.6505 |
PRE | −0.147 | 0.0017 | −0.220 | 0.0007 | −0.066 | 0.3322 |
A | −0.053 | 0.2630 | −0.128 | 0.0505 | 0.017 | 0.7984 |
SH | −0.141 | 0.0026 | −0.187 | 0.0040 | −0.068 | 0.3122 |
R | 0.081 | 0.0842 | 0.096 | 0.1428 | −0.010 | 0.8803 |
UES | −0.050 | 0.2873 | −0.130 | 0.0470 | −0.053 | 0.4358 |
UIS | −0.022 | 0.6341 | −0.057 | 0.3820 | −0.082 | 0.2240 |
SD | 0.095 | 0.0420 | 0.002 | 0.9814 | 0.116 | 0.0845 |
D | 0.157 | 0.0008 | 0.205 | 0.0016 | 0.081 | 0.2323 |
V | 0.107 | 0.0227 | −0.016 | 0.8050 | 0.177 | 0.0084 |
SU | −0.018 | 0.7063 | 0.034 | 0.6035 | 0.048 | 0.4819 |
BD | 0.132 | 0.0048 | 0.182 | 0.0052 | 0.063 | 0.3487 |
SB | 0.273 | 0.0000 | 0.373 | 0.0000 | 0.153 | 0.0234 |
Mini-COPE | The Level of Perceived Stress—PSS-10 | Z | p | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Low/Average | High | |||||||||||||||
M | SD | Min. | Max. | Q1 | Q2 (Me) | Q3 | M | SD | Min | Max. | Q1 | Q2 (Me) | Q3 | |||
General n = 456 | ||||||||||||||||
AC | 2.25 | 0.56 | 0.00 | 3.00 | 2.00 | 2.00 | 2.50 | 2.27 | 0.57 | 0.00 | 3.00 | 2.00 | 2.00 | 3.00 | −0.51 | 0.6114 |
P | 2.12 | 0.54 | 0.00 | 3.00 | 2.00 | 2.00 | 2.50 | 2.14 | 0.63 | 0.00 | 3.00 | 1.75 | 2.00 | 2.50 | −0.63 | 0.5297 |
PRE | 1.87 | 0.58 | 0.50 | 3.00 | 1.50 | 2.00 | 2.00 | 1.74 | 0.71 | 0.00 | 3.00 | 1.50 | 2.00 | 2.00 | −2.14 | 0.0326 |
A | 1.87 | 0.59 | 0.00 | 3.00 | 1.50 | 2.00 | 2.00 | 1.86 | 0.66 | 0.00 | 3.00 | 1.50 | 2.00 | 2.00 | −0.14 | 0.8873 |
SH | 0.99 | 0.57 | 0.00 | 2.50 | 0.50 | 1.00 | 1.50 | 0.84 | 0.63 | 0.00 | 2.50 | 0.50 | 1.00 | 1.50 | −2.55 | 0.0108 |
R | 1.31 | 0.88 | 0.00 | 3.00 | 0.50 | 1.00 | 2.00 | 1.39 | 0.94 | 0.00 | 3.00 | 0.50 | 1.50 | 2.00 | −1.05 | 0.2950 |
UES | 1.82 | 0.73 | 0.00 | 3.00 | 1.50 | 2.00 | 2.00 | 1.68 | 0.78 | 0.00 | 3.00 | 1.00 | 2.00 | 2.00 | −1.64 | 0.1008 |
UIS | 1.64 | 0.74 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | 1.57 | 0.80 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | −0.85 | 0.3935 |
SD | 1.75 | 0.68 | 0.00 | 3.00 | 1.50 | 2.00 | 2.00 | 1.88 | 0.69 | 0.00 | 3.50 | 1.50 | 2.00 | 2.50 | −2.20 | 0.0275 |
D | 0.90 | 0.71 | 0.00 | 2.50 | 0.50 | 1.00 | 1.50 | 1.03 | 0.74 | 0.00 | 3.00 | 0.50 | 1.00 | 1.50 | −1.88 | 0.0606 |
V | 1.38 | 0.61 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | 1.46 | 0.63 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | −1.52 | 0.1288 |
SU | 0.46 | 0.64 | 0.00 | 3.00 | 0.00 | 0.00 | 1.00 | 0.43 | 0.66 | 0.00 | 3.00 | 0.00 | 0.00 | 1.00 | −0.80 | 0.4243 |
BD | 0.72 | 0.59 | 0.00 | 3.00 | 0.00 | 0.50 | 1.00 | 0.81 | 0.62 | 0.00 | 2.50 | 0.00 | 1.00 | 1.00 | −1.62 | 0.1058 |
SB | 1.05 | 0.68 | 0.00 | 3.00 | 0.50 | 1.00 | 1.50 | 1.40 | 0.78 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | −5.06 | 0.0000 |
Women n = 235 | ||||||||||||||||
AC | 2.29 | 0.61 | 0.00 | 3.00 | 2.00 | 2.50 | 3.00 | 2.28 | 0.54 | 0.50 | 3.00 | 2.00 | 2.50 | 2.50 | −0.35 | 0.7290 |
P | 2.17 | 0.49 | 0.50 | 3.00 | 2.00 | 2.00 | 2.50 | 2.20 | 0.56 | 1.00 | 3.00 | 2.00 | 2.00 | 2.50 | −0.44 | 0.6624 |
PRE | 1.91 | 0.57 | 0.50 | 3.00 | 1.50 | 2.00 | 2.00 | 1.73 | 0.69 | 0.00 | 3.00 | 1.25 | 1.50 | 2.00 | −2.29 | 0.0221 |
A | 1.97 | 0.54 | 0.00 | 3.00 | 1.50 | 2.00 | 2.00 | 1.83 | 0.66 | 0.00 | 3.00 | 1.50 | 2.00 | 2.00 | −1.56 | 0.1197 |
SH | 0.94 | 0.55 | 0.00 | 2.50 | 0.50 | 1.00 | 1.50 | 0.77 | 0.61 | 0.00 | 2.50 | 0.00 | 1.00 | 1.00 | −2.23 | 0.0260 |
R | 1.53 | 0.93 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | 1.54 | 0.89 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | −0.10 | 0.9171 |
UES | 2.08 | 0.67 | 0.00 | 3.00 | 1.50 | 2.00 | 2.50 | 1.80 | 0.73 | 0.00 | 3.00 | 1.50 | 2.00 | 2.00 | −2.87 | 0.0041 |
UIS | 1.92 | 0.70 | 0.00 | 3.00 | 1.50 | 2.00 | 2.50 | 1.70 | 0.75 | 0.00 | 3.00 | 1.00 | 2.00 | 2.00 | −2.19 | 0.0289 |
SD | 1.92 | 0.64 | 0.50 | 3.00 | 1.50 | 2.00 | 2.50 | 1.97 | 0.64 | 0.50 | 3.00 | 1.50 | 2.00 | 2.50 | −0.73 | 0.4651 |
D | 0.85 | 0.73 | 0.00 | 2.50 | 0.00 | 1.00 | 1.50 | 1.11 | 0.75 | 0.00 | 3.00 | 0.50 | 1.00 | 1.50 | −2.68 | 0.0073 |
V | 1.57 | 0.56 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | 1.50 | 0.57 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | −0.71 | 0.4790 |
SU | 0.24 | 0.49 | 0.00 | 3.00 | 0.00 | 0.00 | 0.50 | 0.28 | 0.53 | 0.00 | 3.00 | 0.00 | 0.00 | 0.50 | −0.68 | 0.4964 |
BD | 0.68 | 0.62 | 0.00 | 2.50 | 0.00 | 0.50 | 1.00 | 0.86 | 0.64 | 0.00 | 2.50 | 0.50 | 1.00 | 1.00 | −2.18 | 0.0293 |
SB | 1.00 | 0.73 | 0.00 | 3.00 | 0.50 | 1.00 | 1.50 | 1.47 | 0.82 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | −4.42 | 0.0000 |
Men n = 221 | ||||||||||||||||
AC | 2.22 | 0.51 | 0.50 | 3.00 | 2.00 | 2.00 | 2.50 | 2.26 | 0.61 | 0.00 | 3.00 | 2.00 | 2.00 | 3.00 | −0.77 | 0.4438 |
P | 2.08 | 0.57 | 0.00 | 3.00 | 2.00 | 2.00 | 2.50 | 2.06 | 0.72 | 0.00 | 3.00 | 1.50 | 2.00 | 2.50 | −0.02 | 0.9816 |
PRE | 1.83 | 0.58 | 0.50 | 3.00 | 1.50 | 2.00 | 2.00 | 1.75 | 0.73 | 0.00 | 3.00 | 1.50 | 2.00 | 2.00 | −0.69 | 0.4889 |
A | 1.80 | 0.62 | 0.00 | 3.00 | 1.50 | 2.00 | 2.00 | 1.89 | 0.67 | 0.00 | 3.00 | 1.50 | 2.00 | 2.50 | −1.24 | 0.2136 |
SH | 1.02 | 0.58 | 0.00 | 2.50 | 0.50 | 1.00 | 1.50 | 0.95 | 0.65 | 0.00 | 2.50 | 0.50 | 1.00 | 1.50 | −0.88 | 0.3790 |
R | 1.15 | 0.82 | 0.00 | 3.00 | 0.50 | 1.00 | 1.50 | 1.18 | 0.98 | 0.00 | 3.00 | 0.00 | 1.00 | 2.00 | −0.11 | 0.9129 |
UES | 1.62 | 0.72 | 0.00 | 3.00 | 1.00 | 2.00 | 2.00 | 1.51 | 0.83 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | −0.80 | 0.4226 |
UIS | 1.44 | 0.70 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | 1.38 | 0.83 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | −0.50 | 0.6194 |
SD | 1.62 | 0.68 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | 1.76 | 0.75 | 0.00 | 3.50 | 1.50 | 1.75 | 2.50 | −1.45 | 0.1482 |
D | 0.94 | 0.70 | 0.00 | 2.50 | 0.50 | 1.00 | 1.50 | 0.91 | 0.71 | 0.00 | 3.00 | 0.50 | 1.00 | 1.50 | −0.38 | 0.7046 |
V | 1.24 | 0.61 | 0.00 | 2.50 | 1.00 | 1.50 | 1.50 | 1.41 | 0.71 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | −1.90 | 0.0571 |
SU | 0.62 | 0.68 | 0.00 | 2.00 | 0.00 | 0.50 | 1.00 | 0.64 | 0.76 | 0.00 | 3.00 | 0.00 | 0.50 | 1.00 | −0.19 | 0.8529 |
BD | 0.75 | 0.58 | 0.00 | 3.00 | 0.50 | 1.00 | 1.00 | 0.73 | 0.59 | 0.00 | 2.00 | 0.00 | 1.00 | 1.00 | −0.12 | 0.9031 |
SB | 1.08 | 0.65 | 0.00 | 2.50 | 0.50 | 1.00 | 1.50 | 1.30 | 0.72 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | −2.46 | 0.0141 |
Mini-COPE | The Level of Perceived Stress—PSS-10 | Z | p | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Low/Average | High | |||||||||||||||
M | SD | Min. | Max. | Q1 | Q2 (Me) | Q3 | M | SD | Min. | Max. | Q1 | Q2 (Me) | Q3 | |||
Patients after ART procedures n = 183 | ||||||||||||||||
AC | 2.24 | 0.58 | 0.00 | 3.00 | 2.00 | 2.00 | 3.00 | 2.24 | 0.56 | 0.00 | 3.00 | 2.00 | 2.00 | 2.50 | −0.14 | 0.8898 |
P | 2.06 | 0.49 | 0.50 | 3.00 | 2.00 | 2.00 | 2.50 | 2.14 | 0.70 | 0.00 | 3.00 | 2.00 | 2.00 | 2.50 | −1.47 | 0.1419 |
PRE | 1.84 | 0.57 | 0.50 | 3.00 | 1.50 | 2.00 | 2.00 | 1.77 | 0.77 | 0.00 | 3.00 | 1.50 | 2.00 | 2.00 | −0.62 | 0.5351 |
A | 1.85 | 0.60 | 0.00 | 3.00 | 1.50 | 2.00 | 2.00 | 1.86 | 0.76 | 0.00 | 3.00 | 1.50 | 2.00 | 2.50 | −0.66 | 0.5075 |
SH | 1.06 | 0.60 | 0.00 | 2.50 | 0.50 | 1.00 | 1.50 | 0.81 | 0.61 | 0.00 | 2.50 | 0.50 | 0.50 | 1.50 | −2.76 | 0.0057 |
R | 1.24 | 0.85 | 0.00 | 3.00 | 0.50 | 1.00 | 2.00 | 1.25 | 0.92 | 0.00 | 3.00 | 0.50 | 1.00 | 2.00 | −0.01 | 0.9909 |
UES | 1.75 | 0.72 | 0.00 | 3.00 | 1.50 | 2.00 | 2.00 | 1.59 | 0.84 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | −1.18 | 0.2392 |
UIS | 1.63 | 0.71 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | 1.41 | 0.88 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | −1.66 | 0.0964 |
SD | 1.70 | 0.71 | 0.00 | 3.00 | 1.00 | 1.75 | 2.00 | 1.84 | 0.71 | 0.00 | 3.00 | 1.50 | 2.00 | 2.50 | −1.64 | 0.1000 |
D | 1.07 | 0.70 | 0.00 | 2.50 | 0.50 | 1.00 | 1.50 | 1.08 | 0.78 | 0.00 | 3.00 | 0.50 | 1.00 | 1.50 | −0.11 | 0.9091 |
V | 1.42 | 0.58 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | 1.41 | 0.64 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | −0.18 | 0.8609 |
SU | 0.54 | 0.67 | 0.00 | 3.00 | 0.00 | 0.00 | 1.00 | 0.31 | 0.56 | 0.00 | 2.50 | 0.00 | 0.00 | 0.50 | −2.72 | 0.0065 |
BD | 0.78 | 0.62 | 0.00 | 2.50 | 0.00 | 1.00 | 1.00 | 0.71 | 0.61 | 0.00 | 2.50 | 0.00 | 1.00 | 1.00 | −0.77 | 0.4422 |
SB | 1.05 | 0.70 | 0.00 | 3.00 | 0.50 | 1.00 | 1.50 | 1.33 | 0.76 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | −3.04 | 0.0023 |
Patients without ART procedures n = 273 | ||||||||||||||||
AC | 2.25 | 0.55 | 0.50 | 3.00 | 2.00 | 2.00 | 2.50 | 2.30 | 0.57 | 0.50 | 3.00 | 2.00 | 2.50 | 3.00 | −0.56 | 0.5764 |
P | 2.16 | 0.57 | 0.00 | 3.00 | 2.00 | 2.00 | 2.50 | 2.15 | 0.59 | 0.50 | 3.00 | 1.50 | 2.00 | 2.50 | −0.44 | 0.6588 |
PRE | 1.88 | 0.59 | 0.50 | 3.00 | 1.50 | 2.00 | 2.00 | 1.72 | 0.67 | 0.00 | 3.00 | 1.50 | 2.00 | 2.00 | −2.22 | 0.0266 |
A | 1.89 | 0.59 | 0.00 | 3.00 | 1.50 | 2.00 | 2.00 | 1.85 | 0.60 | 0.00 | 3.00 | 1.50 | 2.00 | 2.00 | −0.85 | 0.3934 |
SH | 0.93 | 0.54 | 0.00 | 2.50 | 0.50 | 1.00 | 1.00 | 0.86 | 0.64 | 0.00 | 2.50 | 0.50 | 1.00 | 1.50 | −0.95 | 0.3420 |
R | 1.36 | 0.91 | 0.00 | 3.00 | 0.75 | 1.50 | 2.00 | 1.48 | 0.95 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | −1.18 | 0.2375 |
UES | 1.87 | 0.74 | 0.00 | 3.00 | 1.50 | 2.00 | 2.50 | 1.73 | 0.74 | 0.00 | 3.00 | 1.00 | 2.00 | 2.00 | −1.38 | 0.1691 |
UIS | 1.65 | 0.76 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | 1.66 | 0.73 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | −0.12 | 0.9033 |
SD | 1.78 | 0.65 | 0.00 | 3.00 | 1.50 | 2.00 | 2.00 | 1.91 | 0.69 | 0.00 | 3.50 | 1.50 | 2.00 | 2.50 | −1.48 | 0.1397 |
D | 0.78 | 0.70 | 0.00 | 2.50 | 0.00 | 0.50 | 1.00 | 1.00 | 0.72 | 0.00 | 3.00 | 0.50 | 1.00 | 1.50 | −2.66 | 0.0078 |
V | 1.36 | 0.64 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | 1.50 | 0.62 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | −1.80 | 0.0713 |
SU | 0.40 | 0.61 | 0.00 | 2.00 | 0.00 | 0.00 | 0.75 | 0.50 | 0.70 | 0.00 | 3.00 | 0.00 | 0.00 | 1.00 | −1.14 | 0.2559 |
BD | 0.68 | 0.57 | 0.00 | 3.00 | 0.00 | 0.50 | 1.00 | 0.87 | 0.63 | 0.00 | 2.50 | 0.50 | 1.00 | 1.00 | −2.73 | 0.0063 |
SB | 1.05 | 0.68 | 0.00 | 2.50 | 0.50 | 1.00 | 1.50 | 1.45 | 0.80 | 0.00 | 3.00 | 1.00 | 1.50 | 2.00 | −4.03 | 0.0001 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Nagórska, M.; Obrzut, B.; Ulman, D.; Darmochwał-Kolarz, D. The Need of Personalized Medicine in Coping with Stress during Infertility Treatment. J. Pers. Med. 2021, 11, 56. https://doi.org/10.3390/jpm11010056
Nagórska M, Obrzut B, Ulman D, Darmochwał-Kolarz D. The Need of Personalized Medicine in Coping with Stress during Infertility Treatment. Journal of Personalized Medicine. 2021; 11(1):56. https://doi.org/10.3390/jpm11010056
Chicago/Turabian StyleNagórska, Małgorzata, Bogdan Obrzut, Dariusz Ulman, and Dorota Darmochwał-Kolarz. 2021. "The Need of Personalized Medicine in Coping with Stress during Infertility Treatment" Journal of Personalized Medicine 11, no. 1: 56. https://doi.org/10.3390/jpm11010056
APA StyleNagórska, M., Obrzut, B., Ulman, D., & Darmochwał-Kolarz, D. (2021). The Need of Personalized Medicine in Coping with Stress during Infertility Treatment. Journal of Personalized Medicine, 11(1), 56. https://doi.org/10.3390/jpm11010056